Coloplast A/S (ETR:CBHD)

Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of EUR 17.06 billion. The enterprise value is 20.21 billion.

Market Cap	17.06B
Enterprise Value	20.21B

Important Dates

The next estimated earnings date is Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	207.17M
Shares Outstanding	n/a
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	142.64M

Valuation Ratios

The trailing PE ratio is 31.23 and the forward PE ratio is 21.92.

PE Ratio	31.23
Forward PE	21.92
PS Ratio	4.57
PB Ratio	7.74
P/TBV Ratio	n/a
P/FCF Ratio	24.96
P/OCF Ratio	19.80
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.13, with an EV/FCF ratio of 29.57.

EV / Earnings	36.99
EV / Sales	5.41
EV / EBITDA	17.13
EV / EBIT	19.91
EV / FCF	29.57

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 1.47.

Current Ratio	1.00
Quick Ratio	0.61
Debt / Equity	1.47
Debt / EBITDA	2.75
Debt / FCF	4.75
Interest Coverage	9.54

Financial Efficiency

Return on equity (ROE) is 24.72% and return on invested capital (ROIC) is 11.59%.

Return on Equity (ROE)	24.72%
Return on Assets (ROA)	9.82%
Return on Invested Capital (ROIC)	11.59%
Return on Capital Employed (ROCE)	20.30%
Revenue Per Employee	222,175
Profits Per Employee	32,489
Employee Count	16,639
Asset Turnover	0.58
Inventory Turnover	2.43

Taxes

In the past 12 months, Coloplast has paid 285.53 million in taxes.

Income Tax	285.53M
Effective Tax Rate	34.33%

Stock Price Statistics

The stock price has decreased by -35.26% in the last 52 weeks. The beta is 0.53, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-35.26%
50-Day Moving Average	80.15
200-Day Moving Average	90.54
Relative Strength Index (RSI)	39.24
Average Volume (20 Days)	542

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of EUR 3.74 billion and earned 546.27 million in profits. Earnings per share was 2.42.

Revenue	3.74B
Gross Profit	2.52B
Operating Income	1.02B
Pretax Income	831.80M
Net Income	546.27M
EBITDA	1.14B
EBIT	1.02B
Earnings Per Share (EPS)	2.42

Balance Sheet

The company has 97.32 million in cash and 3.25 billion in debt, giving a net cash position of -3.15 billion.

Cash & Cash Equivalents	97.32M
Total Debt	3.25B
Net Cash	-3.15B
Net Cash Per Share	n/a
Equity (Book Value)	2.20B
Book Value Per Share	9.79
Working Capital	402,159

Cash Flow

In the last 12 months, operating cash flow was 861.69 million and capital expenditures -178.29 million, giving a free cash flow of 683.40 million.

Operating Cash Flow	861.69M
Capital Expenditures	-178.29M
Free Cash Flow	683.40M
FCF Per Share	n/a

Margins

Gross margin is 67.55%, with operating and profit margins of 27.19% and 14.62%.

Gross Margin	67.55%
Operating Margin	27.19%
Pretax Margin	22.27%
Profit Margin	14.62%
EBITDA Margin	30.57%
EBIT Margin	27.19%
FCF Margin	18.29%

Dividends & Yields

This stock pays an annual dividend of 2.95, which amounts to a dividend yield of 3.93%.

Dividend Per Share	2.95
Dividend Yield	3.93%
Dividend Growth (YoY)	4.73%
Years of Dividend Growth	9
Payout Ratio	121.67%
Buyback Yield	-0.25%
Shareholder Yield	3.68%
Earnings Yield	3.20%
FCF Yield	4.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Coloplast has an Altman Z-Score of 5.05 and a Piotroski F-Score of 6.

Altman Z-Score	5.05
Piotroski F-Score	6